Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
The Pharmacogenomics Journal
|
August 5, 2015
Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors
A Emami Riedmaier, O Burk, B A C van Eijck, et al.
The Pharmacogenomics Journal
|
April 4, 2007
Variability in human hepatic MRP4 expression: influence of cholestasis and genotype
U Gradhand, T Lang, E Schaeffeler, et al.
Pharmacogenetics
|
December 12, 2001
The genetic determinants of the CYP3A5 polymorphism
E Hustert, M Haberl, O Burk, et al.
Pharmacogenetics
|
July 27, 2001
Identification and functional characterization of eight CYP3A4 protein variants
R Eiselt, T L Domanski, A Zibat, et al.
Pharmacogenetics
|
June 1, 1996
Nomenclature for human CYP2D6 alleles
A K Daly, J Brockmöller, F Broly, et al.
Systems Biology
|
December 26, 2006
Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways
U Klingmüller, A Bauer, S Bohl, et al.
Clinical Pharmacology and Therapeutics
|
October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting
L V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
The Pharmacogenomics Journal
|
August 5, 2015
Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors
A Emami Riedmaier, O Burk, B A C van Eijck, et al.
The Pharmacogenomics Journal
|
April 4, 2007
Variability in human hepatic MRP4 expression: influence of cholestasis and genotype
U Gradhand, T Lang, E Schaeffeler, et al.
Pharmacogenetics
|
December 12, 2001
The genetic determinants of the CYP3A5 polymorphism
E Hustert, M Haberl, O Burk, et al.
Pharmacogenetics
|
July 27, 2001
Identification and functional characterization of eight CYP3A4 protein variants
R Eiselt, T L Domanski, A Zibat, et al.
Pharmacogenetics
|
June 1, 1996
Nomenclature for human CYP2D6 alleles
A K Daly, J Brockmöller, F Broly, et al.
Systems Biology
|
December 26, 2006
Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways
U Klingmüller, A Bauer, S Bohl, et al.
Clinical Pharmacology and Therapeutics
|
October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting
L V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Page
of 6